每年研究成果
研究成果 1990 2019
2018
2
引文
(Scopus)
Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994
Siu, M. K., Abou-Kheir, W., Yin, J. J., Chang, Y. S., Barrett, B., Suau, F., Casey, O., Chen, W. Y., Fang, L., Hynes, P., Hsieh, Y. Y., Liu, Y. N., Huang, J. & Kelly, K., 八月 17 2018, 於 : Oncotarget. 9, 64, p. 32403 1 p.研究成果: 雜誌貢獻 › 評論/辯論
Bone Neoplasms
Protein-Tyrosine Kinases
Prostatic Neoplasms
Medicine
Neoplasm Metastasis
2017
Corrigendum to “RPS12 increases the invasiveness in cervical cancer activated by c-Myc and inhibited by the dietary flavonoids luteolin and quercetin” [J. Funct. Foods (2015) 19PA (236–247)] (S1756464615004478)(10.1016/j.jff.2015.09.030)
Lin, C-W., Lai, G-M., Chen, K-C., Lin, T. H., Fan, J. J., Hsu, R. L., Chou, C-M., Lin, C-M., Kandaswami, C. C., Lee, M. T. & Cheng, C-H., 二月 1 2017, 於 : Journal of Functional Foods. 29, p. 303 1 p.研究成果: 雜誌貢獻 › 評論/辯論
Luteolin
uterine cervical neoplasms
luteolin
Quercetin
Flavonoids
2016
Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: Identification of functional disparities between azacytidine and decitabine [Oncotarget. 7, (2016), 27363-27378] doi 10.18632/oncotarget.8455
Hsieh, Y. Y., Huang, T. C., Lo, H. L., Jhan, J. Y., Chen, S. T. & Yang, P. M., 五月 10 2016, 於 : Oncotarget. 9, 64, p. 32402 1 p.研究成果: 雜誌貢獻 › 評論/辯論
decitabine
Azacitidine
Drug Discovery
Genomics
Medicine